openPR Logo
Press release

Vascular Stents Market 2023 Top Key Players are Abbott Laboratories, Medtronic, Plc, Cook Medical, Biotronik se & co. kg, B. Braun Melsungen AG, Cordis

02-06-2019 10:37 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Vascular Stents Market

Vascular Stents Market

Market Research Future published a Half-Cooked Research Report on “Global Vascular Stents Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Global Vascular Stents Market - Overview

Vascular stents are tiny tube like medical devices which are places into blood vessels or arteries to open the blockage in the vessels. Vascular stent is the valuable tool for the treatment of the different coronary diseases. Vascular stents are used to widen the narrow vessels so as to minimize the chances of heart attack and chest pain. This stents are prepared from variety of material. According to the WHO, approximately 18 million people died from cardiovascular diseases in 2014. Increasing number of people suffering from cardiovascular diseases is responsible for the driving the market. Additionally, globally 39% of adults aged 18 years and over were overweight whereas 13% were obese. Technological advances and increasing obese population is also contributed in the growth of the market. Other advantages like low risk of infection and short recovery time will also drive the market. However availability of alternative therapy and high cost of ventricular stents may restrain the growth of the market.

Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/1408

Global Vascular Stents Market - Competitive Analysis

Boston Scientific Corporation (US), Abbott Laboratories (US), Medtronic, Plc (UK), Cook Medical (US), Biotronik se & co. kg (Germany), B. Braun Melsungen AG (Germany), Cordis (US), Lombard Medical Technologies (UK), Translumina GmbH (Germany), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Vascular Concepts (India), W.L. Gore & Associates (US), Meril Life Sciences Pvt. Ltd. (India) are some of the prominent players at the forefront of competition in the Global Vascular Stents Market and are profiled in MRFR Analysis.

Many companies are focusing on research and development activity to improve the vascular stent products. Major companies are focusing on the development of biodegradable stents to overcome the disadvantages of other available stents. Some major has adopted strategies of acquisitions and strategic alliances for the growth of the market.

Abbott Laboratories is one of the leading healthcare company headquartered in US. In June 2016, FDA has approved the Absorb bioresorbable Stent for heart. This stents is completely dissolve in the body and used in the treatment of heart complications. Company’s Esprit bioresorbable vascular scaffold is under clinical trials.

December, 2016 - Lombard Medical and MicroPort Scientific Corporation announced strategic partnership and investment agreement. This partnership allowed Lombard Medical to accelerate commercialization in global market with its two key products i.e Aorfix and Altura AAA. Aorfix, the only stent graft to hold global approvals to treat abdominal aortic aneurysms (AAA) with aortic neck angles up to 900, and Altura, a highly innovative stent graft that offers a simple and predictable treatment option for standard abdominal aortic aneurysms anatomy.

Boston Scientific Corporation is a global manufacturer and developer of medical devices headquartered in US. PROMUS Element Plus Stent, REBEL Stent System, SYNERGY Stent are some of the major products of the company. In 2014, company has launched Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Asia Pacific region. In 2015, worldwide sales of the company’s drug-eluting coronary stents were $1.074 billion as compared to $1.151 billion during 2014.

Medtronic is a medical device manufacturer headquartered in UK. It is the world's largest standalone medical technology development company. In 2015 company has develop Stent Graft System System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms. Earlier company’s Resolute Drug-Eluting Stent has shown a very good performance in Diabetic Patients with Heart Disease. Medtronic market was increased by 7% in 2016 compared to 2015.

Cook Medical is an US headquartered company involved in the manufacturing of the medical devices. Approach, Bird's Nest, Advance are some of the major product of the company.

Global Vascular Stents Market - Regional Analysis

Geographically, the global vascular stents market is segmented into four regions. Of which North America commands market for vascular stents due to increasing obese population in North America is the major factor for the growth of the market. Beside this increasing people suffering from various cardiovascular diseases and lack of exercise also contributed in the growth of the market. Europe accounts second largest vascular stents market. While Asia Pacific is the fastest growing market due to rapid development in technology and a huge patient suffering from different vascular diseases. However, The Middle East and Africa has the lowest market for medical robotics because of limited development in medical field.
Browse Full Report @ https://www.marketresearchfuture.com/reports/vascular-stents-market-1408

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vascular Stents Market 2023 Top Key Players are Abbott Laboratories, Medtronic, Plc, Cook Medical, Biotronik se & co. kg, B. Braun Melsungen AG, Cordis here

News-ID: 1564363 • Views:

More Releases from Market Research Future

Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
In an era defined by rapidly evolving cyber threats and digital warfare, the Military Cybersecurity industry is undergoing a fundamental transformation. As nation-states, defense organizations, and allied forces expand their reliance on digital networks, unmanned systems, IoT-enabled platforms, and cloud infrastructures, securing military cyberspace has become a strategic priority. The shifting threat landscape is driving unprecedented demand for advanced cybersecurity solutions that can protect critical defense assets, ensure operational continuity,
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Billion- 2035 | Trend, Demand, Regional Analysis
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Bil …
The Drone Identification Market is gaining significant traction in 2026 as unmanned aerial systems (UAS) become more widespread across commercial, governmental, and recreational applications. With drone usage expanding rapidly, there is a pressing need for effective identification, tracking, and management systems that ensure airspace safety, regulatory compliance, and coordinated operations. This demand is driving investment in advanced technologies and solutions that support remote identification, situational awareness, and secure communications within
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CAGR | MRFR
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services. Market Overview and Growth Trends As per Market
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Companies - Oticon, Demant, Eargo, GN Store Nord
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Compa …
The Hearing Aids Market is experiencing consistent growth as the prevalence of hearing loss increases among both aging and younger populations exposed to noise-related hearing issues. Hearing aids play a critical role in enhancing communication, social interaction, and overall quality of life for individuals with hearing impairment. Advances in digital technology, wireless connectivity, and user-centric designs are further boosting adoption worldwide. Market Overview and Growth Trends As per Market Research Future Analysis,

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients